A detailed history of Axiom Investors LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Axiom Investors LLC holds 62,700 shares of ITCI stock, worth $5.34 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
62,700
Previous 68,421 8.36%
Holding current value
$5.34 Million
Previous $4.69 Million 2.18%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$67.99 - $80.84 $388,970 - $462,485
-5,721 Reduced 8.36%
62,700 $4.58 Million
Q2 2024

Aug 13, 2024

BUY
$64.76 - $79.84 $1.92 Million - $2.36 Million
29,576 Added 76.14%
68,421 $4.69 Million
Q1 2024

May 13, 2024

BUY
$64.37 - $75.65 $2.5 Million - $2.94 Million
38,845 New
38,845 $2.69 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.05B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Axiom Investors LLC Portfolio

Follow Axiom Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

News

Stay updated on Axiom Investors LLC with notifications on news.